Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Orchard Therapeutics has entered a new clinical manufacturing services agreement with PCT Cell Therapy Services.
read more
Orchard Therapeutics and MolMed have extended their collaboration – initiated in April 2018 – for a period of five years through June 2025.
read more
Oregon Freeze Dry Life Sciences announced multiple leadership appointments to its recently created Life Sciences division and the appointment of CDMO veteran Jim Miller to its board of directors.
read more
The lawsuit was filed in response to an Abbreviated New Drug Application, or ANDA, filed by Actavis. In its application, Actavis seeks to market and sell generic versions of the currently approved doses of Contrave®.
read more
Monday, November 13, 2017
Orexigen Therapeutics announced its wholly owned subsidiary and Merck KGaA, Darmstadt, Germany have executed a distributorship agreement for Contrave.
read more
Wednesday, August 21, 2019
Orexo has entered into an exclusive agreement with GAIA AG for a new digital therapy (DTx) for the treatment of Opioid Use Disorder (OUD). Orexo will have the exclusive global commercial rights to the product and intends to launch it in the US in ...
read more
OrganaBio has acquired substantially all of the operating assets of San Diego-based Excellos Inc. to create a bicoastal cell therapy contract development and manufacturing organization.
read more
OrganaBio announced the opening of a new laboratory facility in Irvine, California, further expanding its reach and capabilities from the southeast to the west coast.
read more
OrganaBio announced the opening of a new PBMC processing and cryopreservation laboratory at Excellos Labs in San Diego, further strengthening its nationwide network supporting cell therapy developers and clinical trial sponsors.
read more
Orgenesis it has entered into a Collaboration Agreement with Educell, a European cell therapy company.
read more
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
ORIG3N, announced the launch of a unique partnership with Innovasalud to bring health and wellness DNA Tests to Latin America.
read more
Origenis has entered into a global license and collaboration agreement with Expansion Therapeutics to research and discover small molecule compounds targeting RNA-mediated diseases.
read more
Monday, November 03, 2025
Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug ...
read more
Wednesday, December 14, 2016
The Wisconsin Technology Innovation Initiative (Wi2), a non-profit organization formed to support the School of Medicine and Public Health at the University of Wisconsin-Madison, and Orion Corporation, a Finnish pharmaceutical and diagnostics ...
read more